COVAX AMC

New Gavi Risk Sharing Partnership with MedAccess and the Open Society Foundations to help meet country demand for COVID-19 vaccines

Retrieved on: 
Thursday, April 7, 2022

Gavi, MedAccess, and the Open Society Foundations announce a new partnership to create an innovative Risk Sharing Facility to support the COVAX Cost-Sharing Mechanism.

Key Points: 
  • Gavi, MedAccess, and the Open Society Foundations announce a new partnership to create an innovative Risk Sharing Facility to support the COVAX Cost-Sharing Mechanism.
  • MedAccess, the Open Society Foundations, and Gavi, the Vaccine Alliance today announced a new partnership to create a Risk Sharing Facility to help countries procure additional COVID-19 vaccine doses, including variant-adapted doses in response to risks and shocks.
  • The Open Society Foundations will provide a further procurement guarantee of up to $100 million alongside MedAccess, through the Soros Economic Development Fund.
  • This will help COVAX to respond to country requests for additional doses in the event of a future shock or demand spike.

Prime Minister announces additional funding for COVID-19 vaccination in lower-income countries

Retrieved on: 
Friday, April 8, 2022

The Prime Minister, Justin Trudeau, today announced $220 million in additional funding to support COVID-19 vaccination needs in lower income countries.

Key Points: 
  • The Prime Minister, Justin Trudeau, today announced $220 million in additional funding to support COVID-19 vaccination needs in lower income countries.
  • This additional support builds on the more than $2.7 billion Canada has provided for international assistance in response to COVID-19.
  • It will address barriers to access to COVID-19 vaccines and improve the capacity of lower-income countries to distribute vaccines by ensuring that countries have the financial, operational and technical support they need to get people vaccinated.
  • The Prime Minister made the announcement while participating virtually at the 2022 Gavi COVAX AMC Summit.

DFC and Citi Risk Management Solution Helps Gavi Strengthen the Foundations of the COVAX Facility

Retrieved on: 
Wednesday, September 22, 2021

U.S. International Development Finance Corporation (DFC), in conjunction with Citi, today announced it is providing a risk management solution to Gavi, the Vaccine Alliance (Gavi), to mitigate risk and overcome financial hurdles with governments that are funding COVID-19 vaccine purchases through the COVAX Facility.

Key Points: 
  • U.S. International Development Finance Corporation (DFC), in conjunction with Citi, today announced it is providing a risk management solution to Gavi, the Vaccine Alliance (Gavi), to mitigate risk and overcome financial hurdles with governments that are funding COVID-19 vaccine purchases through the COVAX Facility.
  • The risk management solution provided by the U.S. International Development Finance Corporation will strengthen COVAXs ability to pursue that mission, and we are grateful to DFC, the U.S. government and Citi for that important support.
  • Citis Export & Agency Finance acted as the sole financial advisor throughout the stages of establishing the political risk insurance framework for Gavi.
  • Linklaters LLP provided legal counsel to Gavi on the DFC risk management solution.